Scynexis (SCYX) EPS (Diluted) Growth (1y) (2014 - 2026)
Scynexis (SCYX) EPS (Diluted) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 61.87 Mn | -52.82 Mn | - | 45.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.84% |
| Mar 31, 2026 | -195.65% |
| Dec 31, 2025 | 365.71% |
| Sep 30, 2025 | -198.10% |
| Jun 30, 2025 | 53.56% |
| Mar 31, 2025 | -1,388.58% |
| Dec 31, 2024 | 78.98% |
| Sep 30, 2024 | -57.43% |
| Jun 30, 2024 | -112.17% |
| Mar 31, 2024 | 101.19% |
| Dec 31, 2023 | 3.96% |
| Sep 30, 2023 | 94.11% |
| Jun 30, 2023 | 894.33% |
| Mar 31, 2023 | -331.89% |
| Dec 31, 2022 | 58.76% |
| Sep 30, 2022 | -2,757.01% |
| Jun 30, 2022 | -592.54% |
| Mar 31, 2022 | 6.84% |
| Dec 31, 2021 | 55.75% |
| Sep 30, 2021 | -132.11% |